People with multiple sclerosis (MS) might want to think twice about getting a tattoo, according to a new study published in the Journal of Applied Physiology. The reason is due to the tendency for...
The use of certain disease-modifying therapies (DMTs) in people with multiple sclerosis (MS) increases the risk of precancerous growths in those over 45, a new scientific analysis has found.
The...
Researchers have discovered that a small protein found in beetroot can block the activity of prolyl oligopeptidase (POP), an enzyme that breaks down certain hormones and signalling molecules and...
A recent phase III trial has found that high-dose pharmaceutical-grade biotin (MD1003) does not improve disability or walking speed in people with progressive multiple sclerosis (MS).
This outcome...
Researchers have characterised a new type of T-cell which produces a substance that contributes to the autoimmune response in multiple sclerosis (MS), paving the way for further studies and potential...
A new study has found that an anti-inflammatory drug administered nasally may reduce the progression of multiple sclerosis (MS) in mice.
Researchers focused on molecules called inflammasomes which...
A drug which was rejected by the National Institute for Health & Care Excellence (NICE) in June has now been approved for use on the NHS in England and Wales as the first ever oral treatment for...
A new US data study has found that high blood pressure (hypertension) is considerably more common in people with multiple sclerosis (MS) than those without the condition.
Overall, researchers found...
The US Food and Drug Administration (FDA) in the US has released new recommendations that people with multiple sclerosis (MS) avoid getting dental amalgams, which are fillings that are 50% mercury...
A recent clinical trial of a cancer drug showed it repaired the myelin sheath that multiple sclerosis (MS) attacks, but the findings are bittersweet as the drug’s side effects are too serious for it...
